Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCLDecember 9, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
Care coordination, equity can eliminate disparities for nonwhite patients with DLBCLDecember 8, 2019DLBCLLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Kidney function in African American AML patients not linked to reduced survival compared with whitesDecember 7, 2019AMLLeukemia, Myelodysplasia, Transplantation
Myeloma patients over age 70 can benefit from auto-HC transplantDecember 7, 2019TransplantationMultiple MyelomaLymphoma & Plasma Cell Disorders
FDA approves acalabrutinib for CLL, SLL treatmentNovember 21, 2019Leukemia, Myelodysplasia, Transplantation
Will TP53-mutated AML respond to immunotherapy?November 18, 2019AMLLeukemia, Myelodysplasia, Transplantation
CAR T-cell ‘cocktail’ may overcome antigen escape relapseNovember 18, 2019Lymphoma & Plasma Cell DisordersALL
Researchers seek a way to predict cognitive deficits in children treated for ALLNovember 15, 2019ALLLeukemia, Myelodysplasia, TransplantationPediatrics
Foundation launches direct-to-patient registry in multiple myelomaNovember 13, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Armored CAR T cells elicit responses in NHL patientsNovember 12, 2019DLBCLLymphoma & Plasma Cell Disorders
FDA approves anemia treatment for transfusion-dependent beta thalassemia patientsNovember 8, 2019Anemia
Survival ‘excellent’ after rituximab-bendamustine induction in transplant-eligible MCLNovember 6, 2019Lymphoma & Plasma Cell Disorders